Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 8/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | STS | P08842 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27911645 | 0.89 | HSD17B3 (0.55) | HSD17B3L3MBTL1STSHTR7CES2 | |
| SCHEMBL15988708 | 0.87 | CAPN1 (0.44) | HSD17B3L3MBTL1SMN1; SMN2ALDH1A1CAPN1 | |
| SCHEMBL6832946 | 0.87 | HSD17B3 (0.56) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL4527437 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL16507742 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL16515826 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL16516266 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL10686844 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL8506922 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT | |
| SCHEMBL10683502 | 0.85 | HSD17B3 (0.57) | HSD17B3STSALDH1A1HTR7MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111092225-A | Multifunctional coating layer for lithium battery self-supporting electrode and preparation method thereof | 华东理工大学 | 2020-05-01 | — | — | CN | claimed |
| CN-119346169-A | Preparation method of photocatalytic degradation material for treating cefradine-containing wastewater | 北方工业大学 | 2025-01-24 | — | — | CN | disclosed |
| CN-111092225-B | Self-supporting electrode of lithium-sulfur battery and preparation method thereof | 华东理工大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-111732456-A | Ceramic conductive material and preparation method and application thereof | 苏州蓝晶研材料科技有限公司 | 2020-10-02 | — | — | CN | disclosed |
| CN-111092225-A | Multifunctional coating layer for lithium battery self-supporting electrode and preparation method thereof | 华东理工大学 | 2020-05-01 | — | — | CN | disclosed |
| US-20180155341-A1 | Antibacterial Compounds | JANSSEN SCIENCES IRELAND UC (IE) | 2018-06-07 | — | — | US | disclosed |
| US-8507680-B2 | Production process of a heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2013-08-13 | — | — | US | disclosed |
| US-20120142924-A1 | PRODUCTION PROCESS OF A HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | MITSUBISHI RAYON CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| CN-102030877-B | Narrow-bandgap polypyrrylarylenemethine photoelectric functional polymer material and preparation method thereof | UNIV FUZHOU | 2012-06-06 | — | — | CN | disclosed |
| US-8143407-B2 | Process for production of heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| EP-1481978-B1 | PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | MITSUBISHI RAYON CO (JP) | 2011-09-14 | — | — | EP | disclosed |
| CN-102030877-A | Narrow-bandgap polypyrrylarylenemethine photoelectric functional polymer material and preparation method thereof | UNIV FUZHOU | 2011-04-27 | — | — | CN | disclosed |
| US-20100010224-A1 | PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | MITSUBISHI RAYON CO., LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-7612218-B2 | Process for production of heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20050148775-A1 | Process for production of heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-1481978-A1 | PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | Mitsubishi Rayon Co., Ltd. (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010224-A1 | PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | PIN4, IPO5, HLCS | HSD17B3 1470/4885HPGD 3680/4885L3MBTL1 2684/4885 |
| US-20120142924-A1 | PRODUCTION PROCESS OF A HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | PIN4, NISCH, HLCS | HSD17B3 1552/4885HPGD 3611/4885L3MBTL1 3121/4885 |
| US-20050148775-A1 | Process for production of heteroaryl-type boron compounds with iridium catalyst | PIN4, IPO5, HLCS | HSD17B3 1470/4885HPGD 3680/4885L3MBTL1 2684/4885 |
| US-20180155341-A1 | Antibacterial Compounds | FDPS, SQOR, NDUFS3 | HSD17B3 2511/4885HPGD 976/4885L3MBTL1 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.